Global Erectile Dysfunction Oral Medications Market Research Report 2025

Publication ID:

PB502256014

Publication Date:

February 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Erectile Dysfunction Oral Medications was valued at US$ 139 million in the year 2024 and is projected to reach a revised size of US$ 178 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra)听are oral medications that reverse erectile dysfunction by enhancing the effects of nitric oxide, a natural chemical your body produces that relaxes muscles in the penis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Oral Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Oral Medications.
The Erectile Dysfunction Oral Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erectile Dysfunction Oral Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Oral Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Eli Lilly
Pfizer
Bayer
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
BaiYunShan General Factory
Yabang Pharmacy
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erectile Dysfunction Oral Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erectile Dysfunction Oral Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Erectile Dysfunction Oral Medications Market Overview
1.1 Product Definition
1.2 Erectile Dysfunction Oral Medications by Type
1.2.1 Global Erectile Dysfunction Oral Medications Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Oral Medications by Application
1.3.1 Global Erectile Dysfunction Oral Medications Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce
1.4 Global Erectile Dysfunction Oral Medications Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Oral Medications Revenue 2020-2031
1.4.2 Global Erectile Dysfunction Oral Medications Sales 2020-2031
1.4.3 Global Erectile Dysfunction Oral Medications Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Oral Medications Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Oral Medications Sales Market Share by Manufacturers (2020-2025)
2.2 Global Erectile Dysfunction Oral Medications Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Erectile Dysfunction Oral Medications Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Erectile Dysfunction Oral Medications, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Product Type & Application
2.7 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Date of Enter into This Industry
2.8 Global Erectile Dysfunction Oral Medications Market Competitive Situation and Trends
2.8.1 Global Erectile Dysfunction Oral Medications Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Erectile Dysfunction Oral Medications Players Market Share by Revenue
2.8.3 Global Erectile Dysfunction Oral Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Erectile Dysfunction Oral Medications Market Scenario by Region
3.1 Global Erectile Dysfunction Oral Medications Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Erectile Dysfunction Oral Medications Sales by Region: 2020-2031
3.2.1 Global Erectile Dysfunction Oral Medications Sales by Region: 2020-2025
3.2.2 Global Erectile Dysfunction Oral Medications Sales by Region: 2026-2031
3.3 Global Erectile Dysfunction Oral Medications Revenue by Region: 2020-2031
3.3.1 Global Erectile Dysfunction Oral Medications Revenue by Region: 2020-2025
3.3.2 Global Erectile Dysfunction Oral Medications Revenue by Region: 2026-2031
3.4 North America Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Oral Medications Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Erectile Dysfunction Oral Medications Sales by Country (2020-2031)
3.4.3 North America Erectile Dysfunction Oral Medications Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Oral Medications Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Erectile Dysfunction Oral Medications Sales by Country (2020-2031)
3.5.3 Europe Erectile Dysfunction Oral Medications Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Oral Medications Market Facts & Figures by Region
3.6.1 Asia Pacific Erectile Dysfunction Oral Medications Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Erectile Dysfunction Oral Medications Sales by Region (2020-2031)
3.6.3 Asia Pacific Erectile Dysfunction Oral Medications Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Oral Medications Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Erectile Dysfunction Oral Medications Sales by Country (2020-2031)
3.7.3 Latin America Erectile Dysfunction Oral Medications Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Oral Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Oral Medications Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Erectile Dysfunction Oral Medications Sales by Country (2020-2031)
3.8.3 Middle East and Africa Erectile Dysfunction Oral Medications Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Oral Medications Sales by Type (2020-2031)
4.1.1 Global Erectile Dysfunction Oral Medications Sales by Type (2020-2025)
4.1.2 Global Erectile Dysfunction Oral Medications Sales by Type (2026-2031)
4.1.3 Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2020-2031)
4.2 Global Erectile Dysfunction Oral Medications Revenue by Type (2020-2031)
4.2.1 Global Erectile Dysfunction Oral Medications Revenue by Type (2020-2025)
4.2.2 Global Erectile Dysfunction Oral Medications Revenue by Type (2026-2031)
4.2.3 Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2020-2031)
4.3 Global Erectile Dysfunction Oral Medications Price by Type (2020-2031)
5 Segment by Application
5.1 Global Erectile Dysfunction Oral Medications Sales by Application (2020-2031)
5.1.1 Global Erectile Dysfunction Oral Medications Sales by Application (2020-2025)
5.1.2 Global Erectile Dysfunction Oral Medications Sales by Application (2026-2031)
5.1.3 Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2020-2031)
5.2 Global Erectile Dysfunction Oral Medications Revenue by Application (2020-2031)
5.2.1 Global Erectile Dysfunction Oral Medications Revenue by Application (2020-2025)
5.2.2 Global Erectile Dysfunction Oral Medications Revenue by Application (2026-2031)
5.2.3 Global Erectile Dysfunction Oral Medications Revenue Market Share by Application (2020-2031)
5.3 Global Erectile Dysfunction Oral Medications Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly Erectile Dysfunction Oral Medications Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Erectile Dysfunction Oral Medications Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Erectile Dysfunction Oral Medications Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 S.K. Chemicals
6.4.1 S.K. Chemicals Company Information
6.4.2 S.K. Chemicals Description and Business Overview
6.4.3 S.K. Chemicals Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.4.4 S.K. Chemicals Erectile Dysfunction Oral Medications Product Portfolio
6.4.5 S.K. Chemicals Recent Developments/Updates
6.5 Teva Pharma
6.5.1 Teva Pharma Company Information
6.5.2 Teva Pharma Description and Business Overview
6.5.3 Teva Pharma Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharma Erectile Dysfunction Oral Medications Product Portfolio
6.5.5 Teva Pharma Recent Developments/Updates
6.6 Dong-A ST
6.6.1 Dong-A ST Company Information
6.6.2 Dong-A ST Description and Business Overview
6.6.3 Dong-A ST Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dong-A ST Erectile Dysfunction Oral Medications Product Portfolio
6.6.5 Dong-A ST Recent Developments/Updates
6.7 Petros Pharmaceuticals
6.7.1 Petros Pharmaceuticals Company Information
6.7.2 Petros Pharmaceuticals Description and Business Overview
6.7.3 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product Portfolio
6.7.5 Petros Pharmaceuticals Recent Developments/Updates
6.8 Seoul Pharma
6.8.1 Seoul Pharma Company Information
6.8.2 Seoul Pharma Description and Business Overview
6.8.3 Seoul Pharma Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Seoul Pharma Erectile Dysfunction Oral Medications Product Portfolio
6.8.5 Seoul Pharma Recent Developments/Updates
6.9 BaiYunShan General Factory
6.9.1 BaiYunShan General Factory Company Information
6.9.2 BaiYunShan General Factory Description and Business Overview
6.9.3 BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BaiYunShan General Factory Erectile Dysfunction Oral Medications Product Portfolio
6.9.5 BaiYunShan General Factory Recent Developments/Updates
6.10 Yabang Pharmacy
6.10.1 Yabang Pharmacy Company Information
6.10.2 Yabang Pharmacy Description and Business Overview
6.10.3 Yabang Pharmacy Erectile Dysfunction Oral Medications Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Yabang Pharmacy Erectile Dysfunction Oral Medications Product Portfolio
6.10.5 Yabang Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Oral Medications Industry Chain Analysis
7.2 Erectile Dysfunction Oral Medications Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Oral Medications Production Mode & Process Analysis
7.4 Erectile Dysfunction Oral Medications Sales and Marketing
7.4.1 Erectile Dysfunction Oral Medications Sales Channels
7.4.2 Erectile Dysfunction Oral Medications Distributors
7.5 Erectile Dysfunction Oral Medications Customer Analysis
8 Erectile Dysfunction Oral Medications Market Dynamics
8.1 Erectile Dysfunction Oral Medications Industry Trends
8.2 Erectile Dysfunction Oral Medications Market Drivers
8.3 Erectile Dysfunction Oral Medications Market Challenges
8.4 Erectile Dysfunction Oral Medications Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Eli Lilly
Pfizer
Bayer
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
BaiYunShan General Factory
Yabang Pharmacy

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂